PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis
PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis
Not yet recruiting · NCT07856264 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis | Arterial Occlusive Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Not yet recruiting | Not stated | 2026-10-02 | NCT07856264 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fundación Santa Fe de Bogota | 13 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||